Humana Inc. $HUM Shares Acquired by Russell Investments Group Ltd.

Russell Investments Group Ltd. increased its holdings in Humana Inc. (NYSE:HUM – Free Report) by 9.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 413,336 shares of the insurance provider’s stock after acquiring an additional 34,831 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.34% of Humana worth $158,101,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Johnson Financial Group Inc. purchased a new stake in Humana during the 2nd quarter worth approximately $26,000. Trust Co. of Vermont purchased a new position in shares of Humana during the 2nd quarter valued at approximately $28,000. Bogart Wealth LLC boosted its stake in shares of Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares during the last quarter. MidFirst Bank purchased a new position in shares of Humana during the 2nd quarter valued at approximately $35,000. Finally, Highland Investment Advisors LLC acquired a new stake in shares of Humana during the second quarter worth approximately $43,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. Evercore upgraded shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target for the company in a research note on Wednesday, July 29th. Piper Sandler upped their price target on shares of Humana from $463.00 to $526.00 and gave the company an “overweight” rating in a report on Monday, November 9th. UBS Group increased their price objective on shares of Humana from $405.00 to $495.00 and gave the company a “neutral” rating in a research note on Monday, October 12th. Morgan Stanley raised shares of Humana from an “underweight” rating to an “overweight” rating in a report on Friday, October 9th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Humana from $393.00 to $484.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 10th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Humana presently has a consensus rating of “Moderate Buy” and an average target price of $482.96.

View Our Latest Analysis on Humana

Humana Price Performance

Shares of NYSE HUM opened at $450.38 on Monday. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $456.50. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.65 and a quick ratio of 1.65. The business’s fifty day moving average price is $408.53 and its two-hundred day moving average price is $316.91. The firm has a market capitalization of $54.09 billion, a PE ratio of 43.81, a P/E/G ratio of 2.14 and a beta of 0.65.

Humana (NYSE:HUM – Get Free Report) last posted its earnings results on Friday, November 6th. The insurance provider reported ($0.70) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.00) by $0.30. Humana had a return on equity of 8.50% and a net margin of 0.81%. The company had revenue of $41.16 billion for the quarter, compared to analysts’ expectations of $40.87 billion. During the same period last year, the business posted $3.24 earnings per share. The firm’s quarterly revenue was up 26.1% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.500- EPS. On average, research analysts expect that Humana Inc. will post 9.66 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 24th will be paid a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Thursday, December 24th. Humana’s payout ratio is presently 34.44%.

Insider Transactions at Humana

In other Humana news, insider Joseph Ventura sold 5,495 shares of the company’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $433.85, for a total value of $2,384,005.75. Following the completion of the transaction, the insider owned 21,910 shares in the company, valued at approximately $9,505,653.50. This represents a 20.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.20% of the stock is owned by insiders.

Humana Profile

(Free Report)

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Further Reading

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.